Melatonin - Insomnia in adults
You are here : Home > Formulary Search > Melatonin - Insomnia in adults
Status 1
- Modified release tablets
Melatonin 2mg MR tablets are the recommended preferred 1st line product
Prescribe generically. Circadin is NON-FORMULARY
Status 2
- Immediate release tablets
If immediate onset of action is required or crushed to aid swallowing
Status 3
- Oral solution
Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable
Status 4
- Not Specified
All formulations of melatonin for adults under 55 without neurodevelopmental disorders were agreed by APC as NON-FORMULARY
Documentation
PAD Profile
DO NOT PRESCRIBE FOR UNDER 55 years (without neurodevelopmental disorders)
Other Indications
Below are listed other indications that Melatonin is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Insomnia in adults.
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed that melatonin may be considered for for the short term (up to 13 weeks) adjunctive treatment of primary insomnia in patients aged 55 years or over, where sleep hygiene measures have failed, and insomnia is not likely to resolve soon. CBTi should be offered before melatonin (if available).
In all patients, sleep hygiene and behavioural interventions should be tried prior to considering medication for sleep disorders and should continue to be used alongside melatonin. Sleep | Healthy Surrey
Where treatment is continued beyond 2 years, patient to be advised of limited safety evidence beyond this timeframe and a discussion should be documented in clinical notes.
Melatonin is considered as GREEN status for this patient cohort.